Acute Kidney Injury Treatment Market Synopsis

Acute Kidney Injury Treatment Market Size Was Valued at USD 1.4 Billion in 2023, and is Projected to Reach USD 2.5 Billion by 2032, Growing at a CAGR of 6.6% From 2024-2032.

Acute Kidney Injury (AKI) Treatment Market includes treatments, drugs and therapeutic management and other therapeutic measures to treat acute kidney injury. AKI is characterised by a rapid drop in kidney function, whereby the kidneys cannot remove waste products from the blood thereby leading to life threatening conditions if not corrected. Measures contain haemodialysis, pharmacological therapy, and adequate measures to renally replace or shield the kidney. The target market consists mainly of hospital, clinics, and care facilities that specialise in intensive care and nephrology.

• The Acute Kidney Injury Treatment Market Size is expected to grow globally because diseases such as hypertension and diabetes are common ailments that cause kidney malfunction. KI is also increasing due to the higher incidences of AKI in the geriatric population, increased knowledge regarding the early identification and management of kidney diseases. Advancess made in the department of dialysis and renal replacement therapies have also boosted the need for efficient treatment solutions.
• Furthermore, the tendencies, which require focusing on increasing the efficiency of health care organizations health care outcomes, in particular in critical care settings, including ICUs, are also visible. AKI remains one of the most frequent complications in hospitalized patients because of resulting complications such as surgical operations, infections, and sepsis that require treatment. Realizing the ever-increasing burden of health care, governments and private organizations are investing on nephrology departments along with research work thus adding to the market’s prospect.

Acute Kidney Injury Treatment Market Trend Analysis

Growing Demand for Continuous Renal Replacement Therapy (CRRT)

• The use of CRRT is becoming an important trend in managing AKI especially to patients who are in the ICUs with critical illness. Unlike intermittent dialysis, continuous renal replacement therapy entails a slow and continuous process of taking out waste products for which it is more appropriate to hemodynamically unstable patients. The patient population needing ICU admission and the uses of CRRT in management of MOF are rising, and thereby, healthcare facilities are purchasing improved CRRT tools and strategies. This trend also foresee to continue owing to increased technology advancement in the functioning of CRRT gadgets to become the preferred therapy in the management of AKI in ICU.

Rising Adoption of Telemedicine for AKI Monitoring

• Telemedicine and remote monitoring are also a new trend in the development of the AKI Treatment Market. With validation of digital health in health care organizations, home monitoring gadgets and teleconsultations are gaining fame in managing kidney health. This is especially useful for those living far off from nephrology specialized hospitals which very scarce in many African countries. The COVID-19 telemedicine platforms can help healthcare professionals monitor patient’s kidney function and AKI symptoms so that the patients may not have to visit hospitals frequently. The opportunity to extend telehealth services, due to the improvement of digital presence in the healthcare industry, can be considered as one of the factors that contributes to the market development, especially in regions that face insufficiency of qualified specialists and equipment.

Acute Kidney Injury Treatment Market Segment Analysis:

Acute Kidney Injury Treatment Market is segmented on the basis of Product, Injury and Distribution channel

By Product, Dialysis segment is expected to dominate the market during the forecast period

• Based on the product type, the dialysis segment holds the largest market share and will continue to dominate the Acute Kidney Injury Treatment Market in the forecast period thanks to the increasing demand for it as a reliable treatment of severe kidney failure. Dialysis functions as a lifesaving measures for the ESRD patients, providing the necessary means for clearing the blood from hazardous elements. There are only two main kinds of renal replacement therapies, namely, hemodialysis and peritoneal dialysis, with the increasing application of technology enhancing the treatments’ efficacy and global treatment time. The growth of dialysis centers around the world, together with the development of healthcare services in emerging countries will continue to drive the dominance of the dialysis segment. Thus, emphasis on early detection and treatment of AKI cases especially, those admitted to the Intensive Care Units, should equally contribute to higher use of dialysis products.

By Injury, Pre-renal Injury segment expected to held the largest share

• Out of all the injury types in the Acute Kidney Injury Treatment Market, it is anticipated to be dominated by the pre-renal injury segment. Pre-renal AKI, results from decreased renal perfusion, and it is named so because it occurs before the onset of intrinsic renal disease; this type of AKI constitutes one-half to two-thirds of all cases. These injuries mainly result from dehydration, heart failure, or other causes that cause reduction in blood circulation in the kidneys. It is therefore important that in the management of MVA patients, those in this segment be identified early and treated to prevent further damage of the kidneys. Cardiac diseases, diabetes, sepsis, as well as other conditions that lead to pre-renal azotemia, are on the rise, putting focus on treatment within this segment.

Acute Kidney Injury Treatment Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• Hence, North America is expected to hold the largest market share of the global Acute Kidney Injury Treatment Market in 2023 due to factors including the availability of well-developed healthcare structures, high risks of AKI development because of diseases such as diabetes and hypertension, along with enhancing knowledge of kidney disease. In the present research, U.S. has taken the leading role among the countries of the region due to the developed care system in nephrology field and availability of highly advanced approaches to the dialysis and renal replacement therapy. Rising commitment on experimental technologies of AKI treatment in North America is likely to sustain its dominance in the global market contributing half of the overall market for R&D. Furthermore, government actions strengthening the kidney health and patients help to enhance the region’s leadership.

Active Key Players in the Acute Kidney Injury Treatment Market

• Asahi Kasei Corporation (Japan)
• B. Braun Melsungen AG (Germany)
• Baxter International Inc. (USA)
• DaVita Inc. (USA)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• GE Healthcare (USA)
• Medtronic plc (Ireland)
• Nikkiso Co., Ltd. (Japan)
• Nipro Corporation (Japan)
• Philips Healthcare (Netherlands)
• Quanta Dialysis Technologies (UK)
• Siemens Healthineers (Germany)
• SWS Hemodialysis Care Co. Ltd. (China)
• Terumo Corporation (Japan)
• Toray Medical Co., Ltd. (Japan), Other key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Acute Kidney Injury Treatment Market by Product
 4.1 Acute Kidney Injury Treatment Market Snapshot and Growth Engine
 4.2 Acute Kidney Injury Treatment Market Overview
 4.3 Dialysis
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Dialysis: Geographic Segmentation Analysis
 4.4 Intermittent Hemodialysis
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Intermittent Hemodialysis: Geographic Segmentation Analysis
 4.5 Continuous Renal Replacement Therapy
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Continuous Renal Replacement Therapy: Geographic Segmentation Analysis
 4.6 Sustained Low-Efficiency Dialysis
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Sustained Low-Efficiency Dialysis: Geographic Segmentation Analysis
 4.7 Drug Therapy
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Drug Therapy: Geographic Segmentation Analysis
 4.8 Antibiotics
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Antibiotics: Geographic Segmentation Analysis
 4.9 Diuretics
  4.9.1 Introduction and Market Overview
  4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.9.3 Key Market Trends, Growth Factors and Opportunities
  4.9.4 Diuretics: Geographic Segmentation Analysis
 4.10 Immunosuppressive Agents
  4.10.1 Introduction and Market Overview
  4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.10.3 Key Market Trends, Growth Factors and Opportunities
  4.10.4 Immunosuppressive Agents: Geographic Segmentation Analysis

Chapter 5: Acute Kidney Injury Treatment Market by Injury
 5.1 Acute Kidney Injury Treatment Market Snapshot and Growth Engine
 5.2 Acute Kidney Injury Treatment Market Overview
 5.3 Pre-renal Injury
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Pre-renal Injury: Geographic Segmentation Analysis
 5.4 Intrinsic Renal Injury
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Intrinsic Renal Injury: Geographic Segmentation Analysis
 5.5 Post-renal Injury
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Post-renal Injury: Geographic Segmentation Analysis

Chapter 6: Acute Kidney Injury Treatment Market by Distribution channel
 6.1 Acute Kidney Injury Treatment Market Snapshot and Growth Engine
 6.2 Acute Kidney Injury Treatment Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Ambulatory Surgical Centers
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Acute Kidney Injury Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ASAHI KASEI CORPORATION (JAPAN)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 B BRAUN MELSUNGEN AG (GERMANY)
 7.4 BAXTER INTERNATIONAL INC (USA)
 7.5 DAVITA INC (USA)
 7.6 FRESENIUS MEDICAL CARE AG & CO KGAA (GERMANY)
 7.7 GE HEALTHCARE (USA)
 7.8 MEDTRONIC PLC (IRELAND)
 7.9 NIKKISO CO LTD (JAPAN)
 7.10 NIPRO CORPORATION (JAPAN)
 7.11 PHILIPS HEALTHCARE (NETHERLANDS)
 7.12 QUANTA DIALYSIS TECHNOLOGIES (UK)
 7.13 SIEMENS HEALTHINEERS (GERMANY)
 7.14 SWS HEMODIALYSIS CARE CO LTD (CHINA)
 7.15 TERUMO CORPORATION (JAPAN)
 7.16 TORAY MEDICAL CO LTD (JAPAN)
 7.17 OTHER KEY PLAYERS

Chapter 8: Global Acute Kidney Injury Treatment Market By Region
 8.1 Overview
 8.2. North America Acute Kidney Injury Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product
  8.2.4.1 Dialysis
  8.2.4.2 Intermittent Hemodialysis
  8.2.4.3 Continuous Renal Replacement Therapy
  8.2.4.4 Sustained Low-Efficiency Dialysis
  8.2.4.5 Drug Therapy
  8.2.4.6 Antibiotics
  8.2.4.7 Diuretics
  8.2.4.8 Immunosuppressive Agents
  8.2.5 Historic and Forecasted Market Size By Injury
  8.2.5.1 Pre-renal Injury
  8.2.5.2 Intrinsic Renal Injury
  8.2.5.3 Post-renal Injury
  8.2.6 Historic and Forecasted Market Size By Distribution channel
  8.2.6.1 Hospitals
  8.2.6.2 Ambulatory Surgical Centers
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Acute Kidney Injury Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product
  8.3.4.1 Dialysis
  8.3.4.2 Intermittent Hemodialysis
  8.3.4.3 Continuous Renal Replacement Therapy
  8.3.4.4 Sustained Low-Efficiency Dialysis
  8.3.4.5 Drug Therapy
  8.3.4.6 Antibiotics
  8.3.4.7 Diuretics
  8.3.4.8 Immunosuppressive Agents
  8.3.5 Historic and Forecasted Market Size By Injury
  8.3.5.1 Pre-renal Injury
  8.3.5.2 Intrinsic Renal Injury
  8.3.5.3 Post-renal Injury
  8.3.6 Historic and Forecasted Market Size By Distribution channel
  8.3.6.1 Hospitals
  8.3.6.2 Ambulatory Surgical Centers
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Acute Kidney Injury Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product
  8.4.4.1 Dialysis
  8.4.4.2 Intermittent Hemodialysis
  8.4.4.3 Continuous Renal Replacement Therapy
  8.4.4.4 Sustained Low-Efficiency Dialysis
  8.4.4.5 Drug Therapy
  8.4.4.6 Antibiotics
  8.4.4.7 Diuretics
  8.4.4.8 Immunosuppressive Agents
  8.4.5 Historic and Forecasted Market Size By Injury
  8.4.5.1 Pre-renal Injury
  8.4.5.2 Intrinsic Renal Injury
  8.4.5.3 Post-renal Injury
  8.4.6 Historic and Forecasted Market Size By Distribution channel
  8.4.6.1 Hospitals
  8.4.6.2 Ambulatory Surgical Centers
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Acute Kidney Injury Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product
  8.5.4.1 Dialysis
  8.5.4.2 Intermittent Hemodialysis
  8.5.4.3 Continuous Renal Replacement Therapy
  8.5.4.4 Sustained Low-Efficiency Dialysis
  8.5.4.5 Drug Therapy
  8.5.4.6 Antibiotics
  8.5.4.7 Diuretics
  8.5.4.8 Immunosuppressive Agents
  8.5.5 Historic and Forecasted Market Size By Injury
  8.5.5.1 Pre-renal Injury
  8.5.5.2 Intrinsic Renal Injury
  8.5.5.3 Post-renal Injury
  8.5.6 Historic and Forecasted Market Size By Distribution channel
  8.5.6.1 Hospitals
  8.5.6.2 Ambulatory Surgical Centers
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Acute Kidney Injury Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product
  8.6.4.1 Dialysis
  8.6.4.2 Intermittent Hemodialysis
  8.6.4.3 Continuous Renal Replacement Therapy
  8.6.4.4 Sustained Low-Efficiency Dialysis
  8.6.4.5 Drug Therapy
  8.6.4.6 Antibiotics
  8.6.4.7 Diuretics
  8.6.4.8 Immunosuppressive Agents
  8.6.5 Historic and Forecasted Market Size By Injury
  8.6.5.1 Pre-renal Injury
  8.6.5.2 Intrinsic Renal Injury
  8.6.5.3 Post-renal Injury
  8.6.6 Historic and Forecasted Market Size By Distribution channel
  8.6.6.1 Hospitals
  8.6.6.2 Ambulatory Surgical Centers
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Acute Kidney Injury Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product
  8.7.4.1 Dialysis
  8.7.4.2 Intermittent Hemodialysis
  8.7.4.3 Continuous Renal Replacement Therapy
  8.7.4.4 Sustained Low-Efficiency Dialysis
  8.7.4.5 Drug Therapy
  8.7.4.6 Antibiotics
  8.7.4.7 Diuretics
  8.7.4.8 Immunosuppressive Agents
  8.7.5 Historic and Forecasted Market Size By Injury
  8.7.5.1 Pre-renal Injury
  8.7.5.2 Intrinsic Renal Injury
  8.7.5.3 Post-renal Injury
  8.7.6 Historic and Forecasted Market Size By Distribution channel
  8.7.6.1 Hospitals
  8.7.6.2 Ambulatory Surgical Centers
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research